Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
35M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
7.88K
-
Shares change
-
+7.88K
-
Total reported value, excl. options
-
$455K
-
Value change
-
+$455K
-
Number of buys
-
2
-
Price
-
$57.76
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q4 2023
2 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.88K shares
of 35M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (2.56M shares), Paradigm Biocapital Advisors LP (2.39M shares), ORBIMED ADVISORS LLC (1.7M shares), Bain Capital Life Sciences Investors, LLC (1.33M shares), PERCEPTIVE ADVISORS LLC (1.02M shares), BlackRock Inc. (868K shares), Frazier Life Sciences Management, L.P. (785K shares), VANGUARD GROUP INC (765K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (750K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (591K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.